alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CS292653B

PHIẾU THEO DÕI 

UỐNG THUỐC

Liệu Pháp 12 Liều dành cho Bệnh Nhân Nhiễm Lao Tiềm Ẩn

Lịch Uống Thuốc Của Bạn

(Nhà cung cấp: Chỉ định số lượng thuốc và ngày uống thuốc phù hợp)

Thuốc Số lượng thuốc uống mỗi tuần Tần suất Ngày

Isoniazid: ____ mg

Rifapentine: ____ mg

TỔNG: ______

(Isoniazid: _____, Rifapentine: _____)

Một lần mỗi tuần

trong vòng 12 tuần

(3 tháng)

2 3 4 5 6 7

CN

Bác sỹ có thể bổ sung thêm Vitamin B6 vào phác đồ điều trị của bạn.

Theo Dõi Quá Trình Điều Trị Của Bạn

Ở bảng dưới đây, vui lòng chọn ô tương ứng và ghi rõ ngày mà bạn đã uống thuốc. 

TUẦN Thứ 2 Thứ 3 Thứ 4 Thứ 5 Thứ 6 Thứ 7 Chủ Nhật

VÍ DỤ

5/7 - 5/13 _________ X 5/8 _________ _________ _________ _________ _________

Tuần 1 _________ _________ _________ _________ _________ _________ _________

Tuần 2 _________ _________ _________ _________ _________ _________ _________

Tuần 3 _________ _________ _________ _________ _________ _________ _________

Tuần 4 _________ _________ _________ _________ _________ _________ _________

Tuần 5 _________ _________ _________ _________ _________ _________ _________

Tuần 6 _________ _________ _________ _________ _________ _________ _________

Tuần 7 _________ _________ _________ _________ _________ _________ _________

Tuần 8 _________ _________ _________ _________ _________ _________ _________

Tuần 9 _________ _________ _________ _________ _________ _________ _________

Tuần 10 _________ _________ _________ _________ _________ _________ _________

Tuần 11 _________ _________ _________ _________ _________ _________ _________

Tuần 12 _________ _________ _________ _________ _________ _________ _________

www.cdc.gov/tb
TRIỆU CHỨNG 

DANH MỤC KIỂM TRA Liệu Pháp 12 Liều dành cho Bệnh Nhân Nhiễm Lao Tiềm Ẩn

Tên Bệnh Nhân:

Tác Dụng Phụ Thường Thấy

Hầu hết mọi người đều có thể uống thuốc lao mà không gặp phải bất kỳ vấn đề gì. 

Rifapentine có thể khiến nước tiểu, nước bọt, nước mắt hoặc mồ hôi của bạn chuyển sang 

màu đỏ vàng. Đây là dấu hiệu bình thường và sẽ dần biến mất theo thời gian. 

DỪNG uống thuốc và LIÊN HỆ ngay với bác sỹ hoặc y tá

điều trị lao nếu bạn gặp một trong các vấn đề dưới đây:

□ Chóng mặt hoặc lâng lâng khi ngồi hoặc đứng □ Nước tiểu có màu nâu, màu trà hoặc màu cola

□ Ăn không ngon hoặc không muốn ăn □ Da hoặc lòng trắng mắt ngả vàng

□ Rối loạn tiêu hóa, buồn nôn hoặc ói mửa □ Phát ban hoặc ngứa

□ Đau bụng hoặc tức bụng □ Xuất hiện các vết thâm tím, hoặc nốt đỏ hoặc

□ tím trên da mà không rõ nguyên nhân

□ □ Chảy máu mũi, hoặc xuất huyết lợi hoặc chảy

máu chân răng

Đau phần ngực dưới hoặc ợ nóng

Các triệu chứng giống như cảm cúm kèm theo 

hoặc không kèm theo sốt

□ Mệt mỏi hoặc yếu rõ rệt □ Khó thở

□ Sốt hoặc lạnh □ Đau hoặc ngứa tay, cánh tay hoặc chân

□ Tiêu chảy nặng hoặc phân có màu nhạt □ Cảm thấy buồn phiền hoặc suy sụp

(đi ngoài liên tục)

Vui lòng trao đổi với bác sỹ hoặc y tá nếu bạn có thắc mắc về cách điều trị nhiễm

lao tiềm ẩn.

Thông Tin Liên Hệ của Bác Sỹ/Phòng Khám

Tên người chăm sóc cho bạn: 

Số điện thoại: 

Địa chỉ: 

Thời gian: 

www.cdc.gov/tb
# Employee Spotlight: Tiffani Perry

/ Published May 12, 2023
RICHMOND, VA., 
*Employee spotlight regularly features outstanding non-supervisory personnel from throughout the Defense Logistics Agency Aviation and other DLA employees on Defense Supply Center Richmond, Virginia. Organizational directors may submit names of employees they wish to feature in this column to DLA Aviation Public Affairs.*

**Name:** Tiffani Perry

**Organization:** DLA Aviation’s Supplier Operations Original Equipment Manufacturer Directorate

**Years of service:** 1.5 years

**What is your job title and what do you do specifically?** It is my job as a pre-award contract specialist to prepare purchase requisitions for award so the material can get to the warfighter.

**What is your fondest memory of working for DLA Aviation?**So far, my fondest memory is realizing how far I have come in a short amount of time. I thank the people I’ve worked with over the last 18 months because the volume of information to learn was quite intimidating and a bit overwhelming. It is second nature to me now, thanks to my first supervisor and my experienced team members, who were there to answer questions and assist me.

**What aspect(s) of your current job gives you the most personal satisfaction?  Why?**The thing that I am enjoying the most right now is being able to share what I have learned with new and existing team members. No matter how long you have been working on preparing contracts for award, there is always something to learn, and I enjoy being able to share my discoveries in hopes the information will help the team.

**What are your best practices for achieving goals or accomplishing tasks?** My best practice is staying as organized and detailed as possible. I prepare a task list before each work week, but I remain flexible to accommodate any unexpected tasks that may occur. Physically writing out what needs to be done is essential for me to keep up with all of the moving parts in acquisition.

**What are some of your passions outside of work?**Outside of work, I enjoy taking on new home projects and learning different handywork skills no matter how difficult. I also love going to the movies, reading, playing sports, gardening, and of course, spending time with my family.

**What’s the most thrilling/adventurous thing you have ever done?**I’d like to think that I am quite adventurous. I have gone zip lining, indoor skydiving, and completed a high ropes and obstacle course 30 feet in the air. My goal for 2023 is to skydive.
# DLA Distribution hosts DLA Headquarters FMS Action Officers

/ Published Oct. 23, 2015
NEW CUMBERLAND, Pennsylvania, 
In an effort to familiarize themselves with the Foreign Military Sales process, as well as meet face to face with the team from Defense Logistics Agency Distribution Headquarters, the DLA Headquarters FMS Action Officers visited DLA Distribution in New Cumberland, Pa., on October 22.

Seldon Von Der Hoff, Jr. and James Morgan, both from DLA Headquarters Logistics Operations, met with a team of Distribution headquarters employees to discuss the FMS relationship between DLA Headquarters and DLA Distribution.

“We cannot do it without your help,” said Morgan. “Distribution is the face of the FMS process.”

The morning started with a round table discussion allowing the group to have a better understanding of metrics and FMS processes. 

The group followed up the discussion with a tour of the Eastern Distribution Center at DLA Distribution Susquehanna, before finally touring the FMS area where they were able to first hand observe the pick/pack/ship, double inspection area and the FMS HAZMAT materials and documentation.

“This is the beginning of a beautiful relationship,” stated Morgan.
# C_2013086EN.01001802.xml

| 23.3.2013 | EN | Official Journal of the European Union | C 86/18 |
| --- | --- | --- | --- |

23.3.2013

EN

Official Journal of the European Union

C 86/18

---

Action brought on 4 January 2013 — Sherwin-Williams Sweden/OHIM — Akzo Nobel Coatings International (ARTI)

(Case T-12/13)

2013/C 86/30

Language in which the application was lodged: English

Parties

Parties

Applicant: Sherwin-Williams Sweden AB (Märsta, Sweden) (represented by: L. Ström, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal: Akzo Nobel Coatings International BV (Arnhem, Netherlands)

Other party to the proceedings before the Board of Appeal:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Annul the decision of the OHIM First Board of Appeal No R 2085/2011-1 dated, 18 October 2012, (confirming the decision of the Opposition Division Opposition No B 1 717 142, dated 9 August 2011); |
| --- | --- |

—

Annul the decision of the OHIM First Board of Appeal No R 2085/2011-1 dated, 18 October 2012, (confirming the decision of the Opposition Division Opposition No B 1 717 142, dated 9 August 2011);

| — | Award the costs in favour of the applicant. |
| --- | --- |

—

Award the costs in favour of the applicant.

Pleas in law and main arguments

Pleas in law and main arguments

Applicant for a Community trade mark: The applicant

Applicant for a Community trade mark:

Community trade mark concerned: The figurative mark ‘ARTI’ for goods in class 2 — Community trade mark registration No 9 017 427

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: The other party to the proceedings before the Board of Appeal

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited in opposition: Benelux trade mark registration No 753 216 and International Trade mark registration No 872 478 of the word mark ‘ARTITUDE’ for goods in class 2

Mark or sign cited in opposition:

Decision of the Opposition Division: Upheld the opposition

Decision of the Opposition Division:

Decision of the Board of Appeal: Dismissed the appeal

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 8(1)(b) of Council Regulation No 207/2009.

Pleas in law:

---
CS232274_D

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 

Division of Tuberculosis Elimination

Tuberculosis (TB) Facts

TB and HIV/AIDS

What is TB?

“TB” is short for a disease called tuberculosis. TB is spread through 

the air from one person to another. TB germs are passed through the 

air when someone who is sick with TB disease of the lungs or throat 

coughs, speaks, laughs, sings, or sneezes. Anyone near the sick person 

with TB disease can breathe TB germs into their lungs.

TB germs can live in your body without making you sick. This is called 

latent TB infection. This means you have only inactive (sleeping) TB 

germs in your body. The inactive germs cannot be passed on to anyone 

else. However, if these germs wake up or become active in your body 

and multiply, you will get sick with TB disease.

When TB germs are active (multiplying in your body), this is called 

TB disease. These germs usually attack the lungs. They can also 

attack other parts of the body, such as, the kidneys, brain, or spine. 

TB disease will make you sick. People with TB disease may spread the 

germs to people they spend time with every day.

How does human immunodeficiency virus (HIV) 

infection affect TB?

The HIV, or the AIDS virus, helps TB germs make you sick because it 

weakens your immune system. If you are infected with HIV and with TB 

germs, you have a very big chance of getting TB disease. The TB germs 

are much more likely to become active and attack your lungs and other 

parts of the body.

If you think you may have HIV infection, talk to your doctor about 

getting an HIV test. If you have HIV infection and TB infection, you 

must get treatment right away to keep from getting sicker. Take your 

medicine exactly the way your doctor or health care worker tells you. 

TB drugs are very strong. They can treat TB infection and TB disease, 

even in people with HIV infection.

http://www.cdc.gov/tb

Remember, TB drugs only 

work when you take them 

the way your health care 

worker tells you!
Exhibit
99.2



Certification pursuant to

18 U.S.C. Section 1350,

as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of
2002



Vince A. Elhilow, President and Chief Executive Officer
and Richard D. Aldred, Executive Vice President, Chief Financial Officer and Treasurer of Fidelity Bankshares, Inc. (the Company) each certify in his capacity as an officer of the Company that he has reviewed the annual report of the
Company on Form 10-K for the fiscal ended December 31, 2002 and that to the best of his knowledge:



| | (1) |  | the report fully complies with the requirements of Sections 13(a) of the Securities Exchange Act of 1934; and
| | --- |  | -------------------------------------------------------------------------------------------------------------



| | (2) |  | the information contained in the report fairly presents, in all material respects, the financial condition and results of operations.
| | --- |  | -------------------------------------------------------------------------------------------------------------------------------------



The purpose of this statement is solely to comply with Title 18, Chapter 63,
Section 1350 of the United States Code, as amended by Section 906 of the Sarbanes-Oxley Act of 2002.



|              
|--------------
|March 18, 2003
|Date          



|              
|--------------
|March 18, 2003
|Date
#### Com. v. Keeling

09/30/2015

392 EAL (2015)

Denied

Pa.Super., 120 A.3d 1051
#### The People of the State of New York, Respondent, v Carlton Jones, Appellant.

[62 NYS3d 788]

*624Order, Supreme Court, New York County (Daniel P. Conviser, J.), entered on or about February 16, 2016, which adjudicated defendant a level two sex offender pursuant to the Sex Offender Registration Act (Correction Law art 6-C), unanimously affirmed, without costs.

The record supports the court’s discretionary upward departure to level two. Clear and convincing evidence established aggravating factors that were not adequately taken into account by the risk assessment instrument *(see People v Gillotti,*23 NY3d 841 [2014]). In addition to the underlying sex crime, defendant’s record included a very serious attempted murder conviction and an earlier conviction involving sexual intercourse with a child. These aggravating factors outweighed the mitigating factors cited by defendant.

Concur — Acosta, P.J., Manzanet-Daniels, Gische, Kapnick and Kahn, JJ.
No. 10-5182.

#### James B. Stegeman, Petitioner v. Frank J. Lillig.

562 U.S. 908, 131 S. Ct. 255,

178 L. Ed. 2d 169,

2010 U.S. LEXIS 6899.

October 4, 2010.

Petition for writ of certiorari to the Court of Appeals of Georgia denied.
<PAGE>
                                                                    Exhibit 23.2

            Consent of Independent Registered Public Accounting Firm

We consent to incorporation by reference in the registration statements on Form
S-8 (File Nos. 333-109973, 333-59706, 333-47838, 333-02805, 333-68548), of
Dynamics Research Corporation of our report dated March 26, 2003, with respect
to the consolidated statement of operations of Dynamics Research Corporation and
subsidiaries for the period ended December 31, 2002, and the related statements
of changes in stockholders' equity and comprehensive loss and cash flows, and
the related financial statement schedule, which report is included in the
December 31, 2004 annual report on Form 10-K/A of Dynamics Research Corporation.


/s/ KPMG LLP

Boston, Massachusetts
March 31, 2005
[Federal Register Volume 63, Number 120 (Tuesday, June 23, 1998)]
[Notices]
[Page 34211]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-16602]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION


Aviation Proceedings, Agreements Filed During the Week Ending 
June 12, 1998

    The following Agreements were filed with the Department of 
Transportation under the provisions of 49 U.S.C. Sections 412 and 414. 
Answers may be filed within 21 days of date of filing.
    Docket Number: OST-98-3951.
    Date Filed: June 11, 1998.
    Parties: Members of the International Air Transport Association.
    Subject: PTC2 Telex Mail Vote 943, Algeria-Europe/Mideast/Western 
Africa, r1-Economy Class fares r2-Normal/First/Interm. Intended 
effective date: June 22, 1998
Cynthia Hatten,
Federal Register Liaison.
[FR Doc. 98-16602 Filed 6-22-98; 8:45 am]
BILLING CODE 4910-62-P
<PAGE>

                                                                   EXHIBIT 10.36

                          DYNAMICS RESEARCH CORPORATION

          DEFERRED STOCK COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS

                                    AMENDMENT

      WHEREAS, the above-titled Plan was amended in December 2004 with respect
to deferrals on or after January 1, 2005; and

      WHEREAS, under Section 10 of said Plan, the Board may at any time amend
the Plan, and the Compensation Committee may at any time amend the Plan as the
Committee may determine to be necessary or desirable to conform the Plan to
applicable provisions of Section 409A of the Internal Revenue Code, including
all regulations or other guidance issued thereunder.

      NOW, THEREFORE, consistent with guidance issued by the Internal Revenue
Service under Section 409A of the Internal Revenue Code, Section 3 of the Plan,
regarding Deferral of Fees, is amended by adding the following at the end
thereof:

            "A Director may cancel a deferral election with regard to deferral
      of the Director's Fees or Shares that would otherwise be payable to the
      Director in calendar 2005 and instead have such paid to and includable in
      the income of the Director in 2005. This cancellation opportunity shall be
      granted to such Directors as the Committee may determine.

            In addition, by March 15, 2005, a Director may elect to defer all or
      a portion of the Director's Fees or Shares for 2005 that have not been
      paid or become payable, by written notice to the Administrator."

                                          APPROVED FOR
                                          DYNAMICS RESEARCH CORPORATION



                                          By:_________________________________


                                          Date:________________________________
[Federal Register Volume 63, Number 121 (Wednesday, June 24, 1998)]
[Notices]
[Page 34426]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-16737]


-----------------------------------------------------------------------

GENERAL SERVICES ADMINISTRATION


Public Buildings Service; Notice of Availability of Record of 
Decision; Construction of the New Federal Courthouse, Seattle, WA

    Pursuant to Section 102(2)(C) of the National Environmental Policy 
Act (NEPA) of 1969, as amended, as implemented by the Council of 
Environment Quality, the General Services Administration (GSA) has 
filed with the U.S. Environmental Protection Agency and made available 
to other government and interest private parties, the Record of 
Decision concerning the construction of the new Federal Courthouse, 
Seattle, Washington.
    The Record of Decision is available for review at the following 
location: Seattle Public Library, 1000 Fourth Avenue, Seattle, WA 
(Documents Desk). Additional copies are available by contacting Michael 
D. Levine, 400 15th St., SW., Auburn, WA 98001 or call 253/931-7263. 
The document is also available at the following Internet address: 
www.northwest,gsa.gov/pbs/eis.htm.
L. Jay Pearson,
Regional Administrator.
[FR Doc. 98-16737 Filed 6-23-98; 8:45 am]
BILLING CODE 6820-34-M
# DLA Distribution Anniston highlights Champion of the Month – Mathew Hernandez

/ Published March 31, 2022
NEW CUMBERLAND, Pa., 
In a recent newsletter shared with employees, Defense Logistics Agency Distribution Anniston, Alabama, recognized Transportation Assistant Mathew Hernandez as one of the Champions of the Month.

Hernandez was instrumental in shipping out all weapons-related items on time and correctly.

He is the subject matter expert for transportation in this area and has shared his expertise on several meetings/conference calls with DLA Distribution Headquarters entities and Department of the Army personnel.

His knowledge has also been used in the revamping of the Standard Operating Procedures. His efforts highly impacted weapons metrics and transportation coordination continues to maintain a high standard.
# C_2014031EN.01000602.xml

| 1.2.2014 | EN | Official Journal of the European Union | C 31/6 |
| --- | --- | --- | --- |

1.2.2014

EN

Official Journal of the European Union

C 31/6

---

Request for a preliminary ruling from the Högsta förvaltningsdomstolen (Sweden) lodged on 3 December 2013 — Skatteverket v Hilkka Hirvonen

(Case C-632/13)

2014/C 31/09

Language of the case: Swedish

Referring court

Referring court

Högsta förvaltningsdomstolen

Parties to the main proceedings

Parties to the main proceedings

Applicant: Skatteverket

Applicant:

Defendant: Hilkka Hirvonen

Defendant:

Question referred

Question referred

Does Article 45 TFEU preclude provisions in a Member State’s legislation which mean that a person resident in another Member State — who receives all or almost all his income from the first Member State — can choose between two entirely different systems of taxation, that is to say, either to be taxed at source at a lower tax rate but without the right to such tax relief as is applicable under the ordinary income tax system, or to be taxed on his income under the latter system and thus be able to benefit from the tax relief in question?

---
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

G.M.K., )

)

Appellant, )

)

v. ) Case No. 2D18-4970

)

M.S. and R.N.S., )

)

Appellees. )

___________________________________)

Opinion filed July 31, 2019. 

Appeal from the Circuit Court for Lee 

County; John S. Carlin, Judge.

G.M.K., pro se.

M.S. and R.N.S., pro se.

PER CURIAM.

Affirmed. 

KELLY, LaROSE, and SLEET, JJ., Concur.
<PAGE>

                                                                   EXHIBIT 10.17

                             ABERCROMBIE & FITCH CO.

                                      AWARD
                                STOCK UNIT GRANT
                           ACKNOWLEDGEMENT OF RECEIPT

This Stock Unit Agreement is entered into by and between Abercrombie & Fitch Co.
(the "Company"), and the Associate of the Company whose name appears below (the
  "Associate") in order to set forth the terms and conditions of grant of stock
units, each representing the right to receive one share of Class A Common Stock,
$0.01 par value, of the Company (the "Stock Units"), to the Associate under the
      Abercrombie & Fitch Co. 2002 Stock Plan for Associates (The "Plan").

       ASSOCIATE'S NAME:

       SOCIAL SECURITY #:

       # OF STOCK UNITS:

       DATE OF GRANT:

       VESTING:             Stock Units vest on the anniversary of Date of Grant
                            in accordance with the schedule listed below:

                            Year 1   #    25%
                            Year 2        25%
                            Year 3        25%
                            Year 4        25%

Subject to the terms and conditions of the attached Plan, which are incorporated
herein by reference, the Company hereby grants to the Associate the Stock Units
                               as outlined above.

The Company and the Associate executed this Stock Unit Agreement as of the Date
of Grant set forth above.

ABERCROMBIE & FITCH CO.                    ASSOCIATE

_____________________________________      _____________________________________
Michael Jeffries, Chairman and Chief
Executive Officer